NASDAQ:ORPN
Delisted

Bio Blast Pharma Ltd. Stock Insider Trading

$5.24
+0 (+0%)
At Close: May 27, 2022
Date Action Amount Person Type
Oct 28, 2009 Buy 0 Wang Wenbing Common stock, par value $.001 per share
Oct 28, 2009 Buy 0 Bernstein Drew Common stock, par value $.001 per share
May 01, 2009 Buy 0 Yen Winston C Common stock, par value $.001 per share
INSIDER POWER
0
Last 3 transactions
Buy: 0 | Sell: 0 (Shares)

Based on the 3 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 0 and sold 0 ORPN shares in the last 3 trades.

Click to get the best stock tips daily for free!

About Bio Blast Pharma Ltd.

Bio Blast Pharma Ltd., a clinical development-stage biopharmaceutical company, focuses on the identification, licensing, acquisition, development, and commercialization clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company’s drug candidates under clinical or preclinical development includes Trehalose 90mg/mL IV solution, a mutant protein stabilizer and autophagy enhancer used for protein-based drugs ... ORPN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT